Simon J. Walsh

Showing 1-11 of 11 articles

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Edes I, van der Harst P, Krachhardt F, Thijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

March 17, 2019 | 10.4244/EIJ-D-19-00202

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H-P, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson T, Hill J, Hussein H, Bogaerts K, Morice M, Foley DP

June 14, 2018 | 10.4244/EIJ-D-18-00346

Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco D

April 20, 2018 | 10.4244/EIJ-D-17-00529

Coronary interventions

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function

Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen P, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P

June 20, 2017 | 10.4244/EIJ-D-16-01014

Coronary interventions

Optimal approach to percutaneous intervention for CTO in 2017: a hybrid strategy is now the preferred choice

Walsh S, Hanratty C, Spratt J

February 3, 2017 | 10.4244/EIJV12I15A294

Coronary interventions

The first clinical experience with a novel “locking” microcatheter in chronic coronary total occlusions

Wilson S, Maeramans J, Walsh S, Hanratty C, Meyer-Gessner M, Dens J, Christiansen E, Bufe A, Spratt J

February 3, 2017 | 10.4244/EIJ-D-16-00272

Coronary interventions

The collateral circulation of coronary chronic total occlusions

McEntegart M, Badar A, Ahmad F, Shaukat A, MacPherson M, Irving J, Strange J, Bagnall A, Hanratty C, Walsh S, Werner G, Spratt J

April 8, 2016 | 10.4244/EIJV11I14A310

Coronary interventions

Percutaneous coronary intervention for chronic total occlusions: time to move from the annex to mainstream?

Walsh S, Hanratty C

January 20, 2016 | 10.4244/EIJV11I9A200

A novel approach to the management of occlusive in-stent restenosis (ISR)

Wilson W, Walsh S, Hanratty C, Strange J, Hill J, Sapontis J, Spratt J

March 20, 2014 | 10.4244/EIJV9I11A218

Longitudinal compression: a “new” complication with modern coronary stent platforms – time to think beyond deliverability?

Hanratty C, Walsh S

November 30, 2011 | 10.4244/EIJV7I7A135

Latest news

New issue

Discover the Special Edition on valvular heart disease prepared for PCR London Valves

(3D-TEE model - Optimal implantation)

November 15, 2019

Free access

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Free Access

New this week: RADIAL Trial, AMI with cariogenic shock and DCB in-stent restenosis: A randomised trial

November 20, 2019

Trials Book

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Insight

The SYNTAX score on its way out or … towards artificial intelligence

November 1, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Simon J. Walsh

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke